Key result
This document is a journal masthead and contains no clinical study data.
Why the study?
Does extensive laboratory investigation identify clinically relevant anticoagulant protein deficiencies and fibrinolytic defects in patients with thromboembolic disease?
Does extensive laboratory investigation identify clinically relevant anticoagulant protein deficiencies and fibrinolytic defects in patients with thromboembolic disease?
Testing for protein C deficiency should be performed after discontinuing oral anticoagulant therapy, and routine extensive evaluation of the fibrinolytic system may not be clinically useful for individual patients.
No takes yet. Share an insight, caveat, or question.
Journal masthead yields no clinical data; leaves open value of extensive testing for deficiencies in thromboembolic disease.
Malm et al. (1992) studied this question. This document is a journal masthead and contains no clinical study data.